Discover 2,726 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 2,726
Durvalumab and Tremelimumab in Resectable HCC
for
Hepatocellular Carcinoma
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT05440864
Phase 2, Recruiting
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Boston MA, New York NY, Hackensack NJ, Buffalo NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06121843
Phase 1, Recruiting
Flexible vs. Fixed Diuretic Regimen in the Management of Chronic Heart Failure: A Pilot Study
for
Heart Failure, Heart Diseases
Location: London
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Sex: All
Age: 18+
Code: NCT05594823
Recruiting
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
for
Advanced Solid Tumors Cancer, MSI-H Cancer
Location: Providence RI, Fairfax VA, Charlottesville VA,
Sponsor: Nimbus Wadjet, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06898450
Phase 1, Phase 2, Recruiting
Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation
for
Hematologic Malignancies
Location: Halifax, Montreal, Hamilton, Winnipeg, Vancouver
Sponsor: McMaster University
Sex: All
Age: 16 - 70
Code: NCT01217723
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Cabozantinib to Treat Recurrent Liver Cancer Post Transplant
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
for
Relapsed or Refractory Multiple Myeloma (RRMM)
Location: Halifax, Boston MA, New York NY, Montreal,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06615479
Phase 3, Recruiting
Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B:
for
Hepatitis B, Chronic
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT04070079
Recruiting
Ultrasound Imaging, Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment.
for
Breast Cancer Invasive
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: Female
Age: 0+
Code: NCT00437879
Recruiting
Bandage Contact Lens in Post Operative Ptosis Patients
for
Ptosis, Blepharoptosis
Location: Hamilton
Sponsor: St. Joseph's Healthcare Hamilton
Sex: All
Age: 50+
Code: NCT03375879
Recruiting
Effect of Nasal CPAP Versus NIPPV On Diaphragm Electrical Activity (Edi) In VLBW Preterm Infants
for
Preterm Birth, Premature Lungs,
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 0
Code: NCT06295484
Recruiting
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
for
Metastatic Castration-Resistant Prostate Cancer
Location: Halifax, Chicoutimi, The Bronx NY, Montreal,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT06629779
Phase 3, Recruiting
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis